Pharming Group (NASDAQ:PHAR – Get Free Report) and Immix Biopharma (NASDAQ:IMMX – Get Free Report) are both small-cap medical companies, but which is the superior business? Get Pharming Group alerts:ProfitabilityThis table compares Pharming Group and Immix Biopharma’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Pharming Group -2.19% -3.31% -1.78% Immix Biopharma N/A -205.35% -110.63%Analyst RecommendationsThis is a breakdown of current ratings and price targets for Pharming Group and Immix Biopharma, as reported by MarketBeat.com. Given Immix Biopharma’s higher possible upside, analysts clearly believe Immix Biopharma is more favorable than Pharming Group. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pharming Group $339.84 million 3.02 -$11.84 million ($0.13) -115.34 Immix Biopharma N/A N/A -$21.61 million ($0.77) -2.73Pharming Group has higher revenue and earnings than Immix Biopharma.